|
Market Cap (5-Jul) $86,511,600 (718th) |
Close (30-Jun) $0.63 |
Volume (30-Jun) 55,179 |
Shortsold (19-Jun) 190,561 (0.07%) (455th) |
|
52w High $0.57 |
52w Low $0.275 |
P/E - |
EPS -0.09 |
RCE released this announcement to the ASX on 10 March 2021, 9:47. The announcement is not marked as price sensitive, and is 33 page(s) in length and 3.41MB in size.
You can view all announcements from RCE and see how they appear on a price chart on the announcements page.
At the date of this announcement, RCE was 0.138% short sold according to ASIC data. It was ranked the 407th most shorted stock on the ASX. It remains ranked 455th as of the latest reported data (19 June 2025).
| Other Recent Announcements from RCE | |
|---|---|
| Ethics Approval for Phase I/II UTI Trial Expansion | 29 June 2023, 13:49 |
| Change of Director's Interest Notice - J Graham | 26 June 2023, 15:58 |
| DFI Clinical Trial Outpatient Nurses Appointed | 29 May 2023, 10:54 |
| Recce Presenting at H.C. Wainwright Life Sciences Conference | 10 March 2021, 9:47 |
| Recce Pharmaceuticals Dual Lists on Frankfurt Stock Exchange | 8 March 2021, 9:51 |
| Change of Director's Interest Notice | 25 February 2021, 18:50 |
| Change of Director's Interest Notice | 25 February 2021, 18:46 |
You must be logged in to post a reply.
Recce Pharmaceuticals Ltd 